Samrat Pharmachem informs about compliance certificate

12 Oct 2022 Evaluate
Samrat Pharmachem has informed that it enclosed compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022, received from Link Intime India.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

334.65 -12.95 (-3.73%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...